Association Between Duration of Type 2 Diabetes Mellitus and Decline in Pulmonary Function: A Cross-sectional Observational Study

Authors

  • Sunil Kumar Yadav PG Resident, Department of Physiology, Government Bundelkhand Medical College, Sagar, Madhya Pradesh, India
  • Ravikant Arjariya Professor and Head, Department of Physiology, Government Bundelkhand Medical College, Sagar, Madhya Pradesh, India
  • Anju Jha Associate Professor, Department of Physiology, Government Bundelkhand Medical College, Sagar, Madhya Pradesh, India
  • D. P. Namdev ⁴Assistant Professor, Department of Physiology, Government Bundelkhand Medical College, Sagar, Madhya Pradesh, India
  • Maneesh Jain Associate Professor, Department of Medicine, Government Bundelkhand Medical College, Sagar, Madhya Pradesh, India

Keywords:

Type 2 diabetes mellitus; Pulmonary function test; Spirometry; Duration of diabetes; Restrictive lung disease; FVC; FEV1.

Abstract

Background: Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by persistent hyperglycaemia resulting from insulin resistance and progressive β-cell dysfunction. Although the classical complications of diabetes involve the retina, kidneys, nerves, and cardiovascular system, increasing evidence suggests that the lungs may also represent an important target organ affected by chronic hyperglycaemia. The extensive pulmonary microvascular network and connective tissue matrix are susceptible to non-enzymatic glycation, oxidative stress, and microangiopathic changes associated with long-standing diabetes. These pathological alterations may result in progressive deterioration of pulmonary function. The present study was conducted to evaluate the association between duration of T2DM and decline in pulmonary function among diabetic patients attending a tertiary care centre.
Methods: A hospital-based cross-sectional observational study was conducted among 171 patients with T2DM attending the Department of Medicine, Government Bundelkhand Medical College and Hospital, Sagar, Madhya Pradesh, over a period of 18 months. Demographic, anthropometric, clinical, and biochemical parameters were recorded. Pulmonary function tests (PFTs) were performed using computerized spirometry. The association between duration of diabetes and pulmonary dysfunction was analysed using appropriate statistical methods. A p-value <0.05 was considered statistically significant.
Results: Among the 171 participants, 57.9% had diabetes duration greater than five years. Pulmonary dysfunction was observed in 60.8% of participants, with a restrictive pattern being the most common abnormality (43.3%). Patients with diabetes duration greater than five years showed significantly higher prevalence of abnormal pulmonary function tests compared with those having diabetes duration ≤5 years (74.0% vs. 43.1%; p=0.002). Multivariate logistic regression demonstrated that longer duration of diabetes independently predicted pulmonary dysfunction (Adjusted OR=2.48; 95% CI: 1.32–4.67; p=0.005).
Conclusion: Longer duration of T2DM is significantly associated with decline in pulmonary function. Routine pulmonary function assessment may facilitate early detection of respiratory impairment in patients with longstanding diabetes mellitus.

References

International Diabetes Federation. IDF Diabetes Atlas. 10th

ed. Brussels: International Diabetes Federation; 2021.

American Diabetes Association. Classification and diagnosis

of diabetes: Standards of care in diabetes—2024. Diabetes

Care. 2024;47(Suppl 1):S20-S42.

World Health Organization. Global Report on Diabetes.

Geneva: World Health Organization; 2016.

Wild S, Roglic G, Green A, Sicree R, King H. Global

prevalence of diabetes: Estimates for 2000 and projections

for 2030. Diabetes Care. 2004;27(5):1047-53.

King H, Aubert RE, Herman WH. Global burden of diabetes,

-2025: Prevalence, numerical estimates, and projections.

Diabetes Care. 1998;21(9):1414-31.

Zimmet P, Alberti KG, Shaw J. Global and societal implications

of the diabetes epidemic. Nature. 2001;414(6865):782-7.

Alberti KG, Zimmet PZ. Definition, diagnosis and classification

of diabetes mellitus and its complications. Part 1: Diagnosis

and classification of diabetes mellitus provisional report of a

WHO consultation. Diabet Med. 1998;15(7):539-53.

DeFronzo RA, Ferrannini E, Groop L, Henry RR, Herman

WH, Holst JJ, et al. Type 2 diabetes mellitus. Nat Rev Dis

Primers. 2015;1:15019.

Nathan DM. Long-term complications of diabetes mellitus.

N Engl J Med. 1993;328(23):1676-85.

Shah SH, Sonawane P, Nahar P, Vaidya S, Salvi S.

Pulmonary function tests in type 2 diabetes mellitus and their

association with glycemic control. Indian J EndocrinolMetab.

;17(6):1084-9.

Sinha S, Guleria R, Misra A, Pandey RM, Yadav R, Tiwari S.

Pulmonary functions in patients with type 2 diabetes mellitus

and correlation with anthropometry and microvascular

complications. Indian J Med Res. 2004;119:66-71.

Agarwal AS, Fuladi AB, Mishra G, Tayade BO. Spirometric

abnormalities in patients with type 2 diabetes mellitus. J Assoc

Physicians India. 2010;58:71-3.

Meo SA, Al-Drees AM, Arif M, Al-Rubean K. Lung

function in type 2 Saudi diabetic patients. Saudi Med J.

;27(3):338-43.

Davis WA, Knuiman M, Kendall P, Vu H, Davis TM. Reduced

pulmonary function and its associations in type 2 diabetes:

The Fremantle Diabetes Study. Diabetes Res ClinPract.

;50(2):153-9.

Yeh HC, Punjabi NM, Wang NY, Pankow JS, Duncan BB,

Brancati FL. Cross-sectional and prospective study of lung

function in adults with type 2 diabetes. Diabetes Care.

;31(4):741-6.

Fuso L, Pitocco D, Longobardi A, Zaccardi F, Contu C,

Pozzuto C, et al. Reduced lung diffusion capacity in type 2

diabetes mellitus. Diabetes Metab. 2012;38(5):458-65.

Walter RE, Beiser A, Givelber RJ, O’Connor GT, Gottlieb

DJ. Association between glycemic state and lung function.

Am J RespirCrit Care Med. 2003;167(6):911-6.

Wannamethee SG, Shaper AG, Whincup PH. Body fat

distribution, body composition, and respiratory function in

middle-aged men. Am J ClinNutr. 2005;82(5):996-1003.

Sin DD, Jones RL, Man SF. Obesity is a risk factor for

dyspnea but not for airflow obstruction. Arch Intern Med.

;162(13):1477-81.

Weynand B, Jonckheere A, Frans A, Rahier J. Diabetes

mellitus induces thickening of the pulmonary basal lamina.

Respiration. 1999;66(1):14-9.

van den Borst B, Gosker HR, Zeegers MP, Schols AM.

Pulmonary function in diabetes: A meta-analysis. Chest.

;138(2):393-406.

Benbassat CA, Stern E, Kramer MR, Lebzelter J, Blum I, Fink

G. Pulmonary function in patients with diabetes mellitus. Am

J Med Sci. 2001;322(3):127-32.

Klein OL, Krishnan JA, Glick S, Smith LJ. Systematic review

of pulmonary function in diabetes mellitus. Respir Med.

;104(7):977-87.

Lange P, Groth S, Kastrup J, Mortensen J, Appleyard M,

Nyboe J, et al. Diabetes mellitus, plasma glucose and lung

function in a cross-sectional population study. EurRespir J.

;2(1):14-9.

Ford ES, Mannino DM. Prospective association between

diabetes mellitus and pulmonary function. Diabetes Care.

;27(12):2960-4.

Klein BEK, Klein R, Lee KE. Diabetes, cardiovascular

disease, selected cardiovascular risk factors, and the 14-year

incidence of pulmonary function impairment. Arch Intern

Med. 2006;166(12):1327-33.

Litonjua AA, Lazarus R, Sparrow D, DeMolles D,

Weiss ST. Lung function in type 2 diabetes. Respir Med.

;99(12):1583-90.

Engström G, Hedblad B, Nilsson P, Wollmer P, Berglund G,

Janzon L. Lung function, insulin resistance and incidence of

cardiovascular disease. J Intern Med. 2003;253(5):574-81.

Lazarus R, Sparrow D, Weiss ST. Effects of obesity and fat

distribution on ventilatory function. Chest. 1997;111(4):891-8.

Jones RL, Nzekwu MMU. The effects of body mass index on

lung volumes. Chest. 2006;130(3):827-33.

Sandler M. Is the lung a target organ in diabetes mellitus?

Arch Intern Med. 1990;150(7):1385-8.

Klein OL, Aviles-Santa L, Cai J, Collard HR, Kanaya AM,

Kaplan RC, et al. Pulmonary function in Hispanics/Latinos

with diabetes. Diabetes Care. 2014;37(11):3160-8.

Marvisi M, Bartolini L, Del Borrello P, Brianti M, Marani

G, Guariglia A, et al. Pulmonary function in non-insulindependent

diabetes mellitus. Respiration. 2001;68(3):268-72.

Mori H, Okubo M, Okamura M, Yamane K, Kado S, Egusa

G, et al. Abnormalities of pulmonary function in patients

with non-insulin-dependent diabetes mellitus. Intern Med.

;31(2):189-93.

Schnack C, Festa A, Schwarzmaier-D’Assie A, Haber P,

Schernthaner G. Pulmonary dysfunction in type 1 and

type 2 diabetes mellitus. Am J RespirCrit Care Med.

;153(1):313-6.

Asanuma Y, Fujiya S, Ide H, Agishi Y. Characteristics of

pulmonary function in patients with diabetes mellitus.

Diabetes Res ClinPract. 1985;1(2):95-101.

Matsubara T, Hara F. The pulmonary function and

histopathological studies of the lung in diabetes mellitus.

Nippon IkaDaigakuZasshi. 1991;58(5):528-36.

Davis TM, Knuiman M, Kendall P, Grange V, Davis WA.

Glycemic exposure and pulmonary function in type 2 diabetes.

Diabetes Care. 2004;27(3):752-7.

Meo SA, Al-Drees AM, Shah SF, Arif M, Al-Rubean K. Lung

function and duration of diabetes in type 2 diabetic patients.

J Diabetes Complications. 2006;20(6):382-6.

McKeever TM, Weston PJ, Hubbard R, Fogarty A. Lung

function and glucose metabolism: An analysis of data from

the Third National Health and Nutrition Examination Survey.

Am J Epidemiol. 2005;161(6):546-56.

Downloads

Published

2026-08-05

How to Cite

1.
Yadav SK, Arjariya R, Jha A, Namdev DP, Jain M. Association Between Duration of Type 2 Diabetes Mellitus and Decline in Pulmonary Function: A Cross-sectional Observational Study. IJPBR [Internet]. 2026Aug.5 [cited 2026Aug.6];14(03):232-9. Available from: https://www.ijpbr.in/index.php/IJPBR/article/view/1320